文献速递外周动脉疾病

间歇性跛行血管腔内治疗的自然病史与结局

The Natural History and Outcomes of Endovascular Therapy for Claudication.
PubMed 文献 · Ann Vasc Surg · 2017-05-04

单纯球囊扩张与TASC C/D病变是再干预的独立危险因素。

要点

  • 跛行介入后5年一期通畅率62.5%,保肢率97.2%。
  • 21.8%需再次干预,其中腔内17.7%、开放搭桥7.2%。
  • TASC C/D病变再干预风险升高(HR 1.52)。

核心结论

  • 跛行患者腔内治疗后5年一期通畅率与膝上人工血管旁路相当,二期通畅率超过90%,大截肢率低于3%。
  • TASC C/D病变预示腔内治疗失败,此类患者应考虑外科旁路手术。

研究设计与样本

  • 采用Cox比例风险模型评估再次干预的危险因素。

主要发现

  • 5年生存率为79.9%,一期通畅率为62.5%,保肢率为97.2%。
  • 随访期间21.8%需再次干预,其中腔内再干预17.7%、开放旁路7.2%。
  • 校正年龄、性别和其他合并症后,再次干预的两大危险因素为单纯球囊扩张(无支架)(HR 1.36,P=0.02)和TASC C/D病变(HR 1.52,P=0.03)。

关键数值与推荐

  • 8.2%的患者接受了胫动脉病变介入,35%为TASC II C/D病变。

临床怎么用

  • 跛行患者选择腔内治疗时需评估病变TASC分级,TASC C/D者应考虑开放旁路手术。
  • 单纯球囊扩张(无支架)与再干预风险升高相关,支架策略可能需个体化考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The natural history of claudication is well-characterized and traditional therapy includes risk factor modification and exercise protocols with revascularization reserved for patients who are severely impaired. However, the reduced periprocedural morbidity with endovascular therapy has led physicians to broaden the indications for intervention for peripheral artery disease, and more claudicants are undergoing procedures for disease that is moderately limiting to their lifestyle. This study sought to assess the natural history of patients who have undergone peripheral vascular intervention for claudication. METHODS: All patients who underwent at least 1 peripheral vascular intervention (PVI) for claudication at a single institution from January 2007 to December 2013 were identified. Patient demographics were assessed using the hospital record. Outcomes included secondary endovascular intervention, secondary bypass intervention, amputation, and survival. Cox proportional hazards models were created to assess risk factors for further intervention. RESULTS: Five hundred fifteen patients were identified as having undergone PVI for claudication during the study period. Forty-three percent were female, 37% had diabetes, 31% had coronary artery disease, 26% were current smokers, 6.6% had congestive heart failure, 8.2% had a tibial lesion that was intervened upon, and 35% had a Trans-Atlantic Inter-Society Consensus Document (TASC) II C/D lesion. Actuarial survival at 5 years was 79.9% and 62.5% of patients had primary patency. The limb salvage rate was 97.2%. Over the follow-up period, 21.8% required some type of further intervention: either endovascular (17.7%) or open bypass (7.2%). A Cox proportional hazards model adjusting for age, sex, and other comorbidities showed that the two largest risk factors for requiring reintervention were angioplasty only (no stent; hazard ratio [HR] 1.36, P = 0.02) and TASC C/D lesion (HR 1.52, P = 0.03). CONCLUSIONS: With 5-year follow-up, patients have a primary patency that is comparable to an open prosthetic bypass to an above knee target. In addition, the secondary patency rate was over 90% and the major amputation rate as less than 3%. The presence of a TASC C/D lesion was predictive of failure of endovascular therapy, and surgical bypass should be considered in these patients.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Saraidaridis JT, Ergul EA, Clouse WD, et al. The Natural History and Outcomes of Endovascular Therapy for Claudication. Ann Vasc Surg. 2017. PMID: 28479467. doi:10.1016/j.avsg.2017.04.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。